BIOCERES and UNION ACQUISITION CORP. announce execution of definitive share exchange agreement 


Transaction Expected to Position Bioceres to Execute on Compelling Growth Opportunities in the Global Agricultural Biotechnology Markets, expected to result in a combined company with an anticipated initial enterprise value of approximately U.S.$456 million, assuming no redemptions of UAC public shares. Immediately upon consummation of the transaction, UAC will change its name to Bioceres Crop Solutions and is expected to continue its listing on The transaction, which is expected to close in the first quarter of 2019, is subject to customary closing conditions, including receipt of the requisite approval of UACs shareholders. There is no minimum cash condition to closing. With proceeds from this transaction remaining after any redemptions of UAC public shares, Bioceres will consolidate its ownership interest in key subsidiary Rizobacter up to 80%. Following the completion of the business combination, the combined company will be led by Federico Trucco, Chief Executive Officer of Bioceres. Kyle Bransfield and Juan Sartori, currently UBS Investment Bank is acting as exclusive capital markets advisor to UAC. Atlantic-Pacific Capital, Inc., Ladenburg Thalmann & Co. Inc. and Brookline Juan Sartori, Chairman of UAC, said: As a Global Agriculture investor, having the opportunity to invest in a pioneer in the ag-tech space that has built a market leading position in Latin America is a unique opportunity. We believe the global growth potential of Bioceres HB4 family of products represents a solutions to the growing global food shortage challenge in an environmentally responsible way. Weve been extremely impressed with Bioceres …[Read on via official release]

Source: US SEC
View full document: 8-K_for_Union_Acquisition_Corp_8-K-11-09-2018